Resmed (RMD) Non-Current Deferred Tax Liability (2010 - 2026)

Resmed (RMD) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $77.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 1.33% year-over-year to $77.9 million; the trailing twelve-month figure through Mar 2026 stood at $77.9 million (down 1.33% YoY), and the FY2025 full-year result was $77.7 million, down 2.09% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $77.9 million, roughly flat from $78.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $113.0 million in Q1 2023 and bottomed at $9.7 million in Q2 2022.
• The 5-year median for Non-Current Deferred Tax Liability is $79.0 million (2025), against an average of $72.8 million.
• The widest annual swing landed in 2023, when Non-Current Deferred Tax Liability jumped 955.13%; it then dropped 23.4% in 2024.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $107.5 million in 2022, then fell by 16.98% to $89.3 million in 2023, then fell by 13.75% to $77.0 million in 2024, then gained by 1.29% to $78.0 million in 2025, then dropped by 0.08% to $77.9 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $77.9 million (Q1 2026), $78.0 million (Q4 2025), and $77.6 million (Q3 2025), per Business Quant data.

Peer Comparison